DOI: 10.1021/acsmedchemlett.6c00413 ISSN: 1948-5875
Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer
Ram W. SabnisAbstract
Provided herein are novel compounds as SMARCA2 inhibitors, pharmaceutical compositions, use of such compounds in treating non-small cell lung cancer (NSCLE), and processes for preparing such compounds.